Medical Innovation Exchange

RWE

Digital Continuity: Strategies for Product Recall Resilience

Digital Continuity: Strategies for Product Recall Resilience     The mission to bring meaningful innovation to market and improve patient lives is paired with the requirement that such innovations are held to the highest quality. There were 70 class I U.S. medical device recall events in 2022, a category that the FDA reserves for problems that …

Digital Continuity: Strategies for Product Recall Resilience Read More »

AI and the Lack of Diversity in Data: Implications and the Path Forward for Rare Disease Research

AI and the Lack of Diversity in Data: Implications and the Path Forward for Rare Disease Research     Artificial intelligence (AI) and machine learning (ML) are poised to be play a pivotal role in clinical trials by automating patient recruitment, data collection and analysis. However, most AI algorithms primarily rely on databases from populations of …

AI and the Lack of Diversity in Data: Implications and the Path Forward for Rare Disease Research Read More »